-
-
-
-
-
-
-
Ligand completes $739M acquisition of XOMA Royalty
-
-
-
-
-
-
-
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
-
-
-
-
-
-
-
Ligand to acquire XOMA Royalty for $739 million in cash deal
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
-
-
-
-
-
-
-
Ligand Pharma (LGND) Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
-
-
-
-
-
-
-
Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
-
-
-
-
-
-
-
Ligand to Acquire APEIRON Biologics AG for $100 Million
-
1,180,385 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

